MPR Weekly Dose 85 - Chantix recalled; Kimyrsa for ABSSSI; Aduhelm label update; Blood lead test recall; Keytruda changes

<p><span style="font-weight: 400;">This week Pfizer recalled their smoking cessation therapy Chantix. A treatment for acute bacterial skin and skin structure infections becomes available. Aduhelm, the newly approved Alzheimer Disease treatment, has its label updated. A blood lead level test is recalled, and there's updates to the cancer drug Keytruda.</span></p>